on Facebook
on Twitter
on YouTube
Document Information
A Review of Recent Advances in Knowledge About Methadone Maintenance Treatment
This report, which provides a knowledge base for the development of methadone maintenance treatment clinical guidelines in Switzerland, reviews the world-wide literature (except for Switzerland, which is the subject of a separate investigation) on such treatment and existing guidelines. Articles on methadone maintenance treatment and concurring treatment modalities are discussed in detail, as well as existing knowledge about specific populations, such as pregnant addicts and addicts with HIV or tuberculosis. Research on prognostic factors to patients' responses to treatment and perceptions of opiate dependent persons are also reviewed to ascertain their value to practitioners in managing methadone maintenance treatment and in assessing the best possible treatment. A final chapter describes other substitution treatments in comparison to methadone maintenance and synthesizes the information of the review into a structured information source for thinking about guideline development.
Support RAND Research — Buy This Product!
Paperback Cover Price: $15.00
Discounted Web Price: $13.50
Pages: 116
ISBN/EAN: 0-8330-3091-4
Free, downloadable PDF file(s) are available below.
RAND makes an electronic version of this document available for free as a public service. If you find this information valuable, please consider purchasing a paper copy of the full document to help support RAND research.
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
Contents
Chapter One:
Introduction
Chapter Two:
Study Design
Chapter Three:
Guidelines and Clinical Practice Recommendations
Chapter Four:
Methadone - Characteristics of the Drug
Chapter Five:
Treatment Outcome Studies
Chapter Six:
Special Populations
Chapter Seven:
Studies Describing Psychosocial and Other Non-Pharmacological Aspects of Treatment
Chapter Eight:
Perceptions of Addicts of Methadone Maintenance Treatment
Chapter Nine:
Methadone Maintenance Treatment As Compared to Other Substitution Treatments
Chapter Ten:
Conclusions: Recommendations for Guideline Development
The research described in this report was performed within RAND Europe and RAND's Drug Policy Research Center.
The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.
Top
RAND® is a registered trademark. Copyright © 1994-2010 RAND Corporation. Last Modified: May 22, 2009 